Clinical Trial Update: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial examining Semaglutide's impact on immune and biological processes in Alzheimer's disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Alzheimers Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-02-24